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n sympathetic neurons, unlike most nonneuronal cells,
growth factor withdrawal–induced apoptosis requires the
development of competence in addition to cytochrome 
 
c
 
release to activate caspases. Thus, although most non-
neuronal cells die rapidly with cytosolic cytochrome 
 
c
 
alone, sympathetic neurons are remarkably resistant unless
they develop competence. We have identiﬁed endogenous
X-linked inhibitor of apoptosis protein (XIAP) as the essential
postcytochrome 
 
c
 
 regulator of caspase activation in these
neurons. In contrast to wild-type neurons that are resistant
to injection of cytochrome 
 
c
 
, XIAP-deﬁcient neurons died
I
 
rapidly with cytosolic cytochrome 
 
c
 
 alone. Surprisingly,
the release of endogenous Smac was not sufﬁcient to
overcome the XIAP resistance in sympathetic neurons. In
contrast, the neuronal competence pathway permitted
cytochrome 
 
c
 
 to activate caspases by inducing a marked
reduction in XIAP levels in these neurons. Thus, the removal
of XIAP inhibition appears both necessary and sufﬁcient for
cytochrome 
 
c
 
 to activate caspases in sympathetic neurons.
These data identify a critical function of endogenous XIAP
in regulating apoptosis in mammalian cells.
 
Introduction
 
The ability of cells to induce apoptosis and die is important
during development and is crucial for the maintenance of
homeostasis (Vaux and Korsmeyer, 1999). Dysregulation of
the apoptotic pathway is associated with many pathological
conditions. For example, decreased apoptosis contributes to
cancer progression (Green and Evan, 2002), whereas in-
creased apoptosis leads to loss of neural cells during stroke,
spinal cord injury and in many neurodegenerative diseases
(Yuan and Yankner, 2000). Therefore, understanding how
cells regulate apoptosis has important therapeutic implica-
tions in many pathological conditions.
The mechanism of neuronal apoptosis has been widely
studied in sympathetic neurons that are dependent on NGF
for survival. Deprivation of NGF induces an apoptotic neu-
ronal death within 24–48 h after NGF removal in culture
(Deckwerth and Johnson, 1993; Deshmukh and Johnson,
1997). This death is prevented by macromolecular synthesis
inhibitors such as cycloheximide (Martin et al., 1988), is de-
pendent on Bax (Deckwerth et al., 1996), and is executed by
the caspase proteases (Deshmukh et al., 1996; Troy et al.,
1996; McCarthy et al., 1997).
Activation of caspases is a crucial point at which cells be-
come committed to die during apoptosis (Deshmukh et al.,
2000; Denault and Salvesen, 2002). In most mammalian
cells, including sympathetic neurons, caspase activation is
triggered by the release of cytochrome 
 
c
 
 from mitochondria
to cytosol (Deshmukh and Johnson, 1998; Neame et al.,
1998; Wang, 2001). Data from several cell-free studies indi-
cate that cytochrome 
 
c
 
 released from the mitochondria binds
to Apaf-1 and promotes its oligomerization. Procaspase-9
is then recruited to bind oligomerized Apaf-1 to form the
apoptosome complex where caspase-9 becomes activated.
Activated caspase-9 then cleaves and activates other caspases,
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such as caspase-3, to induce rapid apoptosis and cell death
(Wang, 2001).
Members of the inhibitor of apoptosis proteins (IAPs) can
regulate caspase activity by binding directly to activated cas-
pases and inhibiting their function (Salvesen and Duckett,
2002). The IAP family includes X-linked IAP (XIAP), cellu-
lar IAP-1 (cIAP-1), cIAP-2, neuronal apoptosis inhibitory
protein, Survivin, melanoma IAP, and Bruce, all of which
contain one or more repeats of the characteristic baculovirus
IAP repeat domain. Overexpression of IAPs blocks apoptosis
in many cells (Deveraux et al., 1998; Duckett et al., 1998;
Simons et al., 1999), including in sympathetic neurons
(Wiese et al., 1999; Yu et al., 2003). The IAPs themselves
can potentially be regulated in cells by at least two mecha-
nisms. First, mitochondrial proteins such as Smac/DIABLO
and HtrA2/Omi, when translocated to the cytosol during
apoptosis, can bind to and inhibit multiple IAPs (Du et al.,
2000; Verhagen et al., 2000; Suzuki et al., 2001a). Second,
several IAPs including XIAP, cIAP-1, and cIAP-2 contain a
RING finger domain that can function as an E3 ubiquitin
ligase and target themselves and other proteins for protea-
some-mediated degradation (Yang et al., 2000; Suzuki et al.,
2001b; MacFarlane et al., 2002). However, the mechanism
by which degradation of IAPs is regulated in mammalian
cells in not known.
In primary fibroblasts and many cell lines, cytosolic mi-
croinjection of cytochrome 
 
c
 
 induces a rapid, caspase-depen-
dent apoptotic death, thus indicating that cytosolic accumu-
lation of cytochrome 
 
c
 
 alone is sufficient to activate caspases
in these nonneuronal cells (Li et al., 1997; Brustugun et al.,
1998; Juin et al., 1999; Chang et al., 2000). In contrast, cy-
tochrome 
 
c
 
, although necessary, is not sufficient to induce
cell death in sympathetic neurons. NGF-maintained sympa-
thetic neurons are remarkably resistant to cytosolic microin-
jection of cytochrome 
 
c
 
, thus pointing to a stringent postcy-
tochrome 
 
c
 
 regulation of caspase activation in these neurons
(Deshmukh and Johnson, 1998; Neame et al., 1998). Im-
portantly, NGF deprivation activates a novel pathway, called
development of competence, which is necessary to allow cy-
tochrome 
 
c
 
 to activate caspases and induce cell death in sym-
pathetic neurons (Deshmukh and Johnson, 1998). There-
fore, NGF deprivation–induced apoptosis in sympathetic
neurons requires the activation of two pathways: a cyto-
chrome 
 
c
 
 release pathway that is dependent on protein syn-
thesis and Bax function; and a development of the compe-
tence pathway that requires neither protein synthesis nor
Bax function (Deshmukh and Johnson, 1998).
Recent data suggests that the inability of cytosolic cyto-
chrome 
 
c
 
 alone to induce death in NGF-maintained sympa-
thetic neurons is due to a block in caspase activation by the
IAPs. Microinjection of excess exogenous Smac that inhibits
IAPs overcomes this block and permits cytochrome 
 
c
 
 to in-
duce a rapid, caspase-dependent death in these neurons
(Deshmukh et al., 2002). Thus, the target of the compe-
tence pathway is likely to be IAPs, although which IAP may
be important and the exact mechanism by which the compe-
tence pathway permits cytochrome 
 
c
 
 to induce neuronal
apoptosis is not known. Here, we identify XIAP as the criti-
cal inhibitor of caspase activation in sympathetic neurons.
We find that XIAP mRNA and protein are both selectively
decreased when neurons develop competence and become
permissive for cytochrome 
 
c
 
–mediated caspase activation.
Importantly, although cytochrome 
 
c
 
 alone is incapable of in-
ducing cell death in wild-type neurons, it is remarkably suf-
ficient to induce a rapid apoptotic death in XIAP-deficient
neurons. These data identify an essential function for endog-
enous XIAP in regulating apoptosis in mammalian cells and
indicate that removal of XIAP inhibition is both necessary
and sufficient for cytochrome 
 
c
 
 to activate caspases during
neuronal apoptosis.
 
Results
 
Removal of IAP inhibition is necessary for cytochrome 
 
c
 
 to induce apoptosis in sympathetic neurons
 
NGF deprivation–induced cytochrome 
 
c
 
 release and devel-
opment of competence are both necessary for apoptosis in
sympathetic neurons. These two pathways are distinct from
each other because whereas cycloheximide addition and Bax
deficiency block the cytochrome 
 
c
 
 release pathway, neither
one blocks the development of the competence pathway
(Deshmukh and Johnson, 1998). Thus, whereas microinjec-
tion of exogenous cytosolic cytochrome 
 
c
 
 is not sufficient to
induce cell death in NGF-maintained neurons, it can do so
in NGF-deprived, cycloheximide-treated neurons or NGF-
deprived, Bax-deficient neurons, both of which develop
competence (Fig. 1; Deshmukh and Johnson, 1998). Bax
deficiency or cycloheximide addition itself does not induce
competence; they are simply used as tools for blocking the
cytochrome 
 
c
 
 release pathway, without which the NGF-
deprived neurons would die, thereby precluding us from
studying the competence pathway.
Figure 1. The ability of exogenously microinjected Smac to inhibit 
IAPs is necessary for permitting cytochrome c to induce death in 
sympathetic neurons. NGF-maintained mouse sympathetic neurons 
were microinjected with either cytochrome c or wild-type AVPI-Smac 
alone, or cytochrome c along with wild-type AVPI or mutant MVPI-
Smac. Parallel cultures of sympathetic neurons that were deprived of 
NGF in the presence of cycloheximide ( NGF CHX) for 36 h were 
injected with cytochrome c as a positive control for competence. 
Viability of microinjected cells 3, 6, and 20 h after these injections is 
shown. Data are mean   SEM for three experiments with  100 cells 
counted for each time point per experiment. 
Neuronal apoptosis requires the removal of XIAP |
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The resistance of NGF-maintained neurons to cytosolic
cytochrome 
 
c
 
 is overcome with microinjection of excess ma-
ture Smac (Fig. 1; Deshmukh et al., 2002). To confirm that
exogenous Smac permitted cytochrome 
 
c
 
 to induce apopto-
sis by inhibiting IAPs in these neurons, we examined
whether a Smac mutant protein that cannot inhibit IAPs as a
consequence of a single, alanine-to-methionine amino acid
change in its mature NH
 
2
 
 terminus was capable of permit-
ting cytochrome 
 
c
 
 to induce death in sympathetic neurons.
Unlike wild-type AVPI-Smac, the mutant MVPI-Smac can-
not bind to IAPs and relieve their inhibition of caspases
(Chai et al., 2000). We found that unlike wild-type AVPI-
Smac, the mutant MVPI-Smac was incapable of cooperating
with cytochrome 
 
c
 
 to induce death in NGF-maintained
sympathetic neurons (Fig. 1). Less than 5% of cells that were
injected with wild-type AVPI-Smac and cytochrome 
 
c
 
 were
viable 20 h after the injections, whereas almost 80% of cells
that were injected with the mutant MVPI-Smac and cyto-
chrome 
 
c
 
 were viable at that time (Fig. 1). Thus, cytochrome
 
c
 
 was able to induce apoptosis in NGF-maintained sympa-
thetic neurons only if the functions of one or more Smac-
inhibitable IAPs were blocked in these neurons.
 
Levels of XIAP are reduced when sympathetic neurons 
develop competence
 
To identify the specific IAPs that regulated caspase activa-
tion during sympathetic neuronal apoptosis, we first exam-
ined which IAPs were expressed in sympathetic neurons.
Western data show that NGF-maintained sympathetic neu-
rons express multiple IAPs including XIAP, cIAP-1, and
cIAP-2 (Fig. 2 a). Importantly, we examined whether the
levels of any IAPs were altered under conditions where neu-
rons develop competence. Sympathetic neurons that are de-
prived of NGF in the presence of cycloheximide for 24 h de-
velop competence and become permissive for cytochrome
 
c
 
–mediated apoptosis (Fig. 1; Deshmukh and Johnson, 1998).
Cycloheximide addition was used to block the cytochrome 
 
c
 
release pathway specifically, thus maintaining the survival of
competent neurons. Among the IAPs examined, we found
the levels of XIAP protein to be most dramatically reduced
in neurons that develop competence. Levels of XIAP protein
in the competent, NGF-deprived, cycloheximide-treated
neurons were reduced to 30% of NGF-maintained control
neurons (Fig. 2, a and b). In contrast, the levels of cIAP-1
and cIAP-2 were reduced, but only marginally to 65–80%
of NGF-maintained levels (Fig. 2, a and b).
Another method to induce competence in sympathetic
neurons, which does not include cycloheximide addition, is
to deprive Bax-deficient neurons of NGF for 24 h. Bax defi-
ciency, like cycloheximide addition, blocks the cytochrome 
 
c
 
release pathway specifically and therefore allows us to main-
tain the survival of NGF-deprived neurons that develop
competence (Deshmukh and Johnson, 1998). We compared
the levels of XIAP in NGF-maintained and NGF-deprived
conditions in Bax-deficient neurons. Levels of XIAP protein
were markedly reduced in the NGF-deprived condition
when neurons developed competence (Fig. 2 c). We also ex-
amined the levels of XIAP in NGF-deprived, caspase inhibi-
tor (50 
 
 
 
M zVAD-FMK)-treated neurons. These neurons
are arrested after cytochrome 
 
c
 
 release, at the point of caspase
activation. A marked reduction in XIAP levels was also seen
in the NGF-deprived-zVAD–treated neurons (Fig. 2 d).
Thus, NGF deprivation induced the loss of XIAP in multi-
ple conditions where the competence pathway was activated.
NGF deprivation is known to cause a global inhibition of
protein synthesis in sympathetic neurons (Deckwerth and
Johnson, 1993). Thus, the dramatic reduction in XIAP pro-
tein levels after NGF deprivation may simply reflect a rapid
turnover of XIAP protein. To examine this possibility, we
inhibited protein synthesis in NGF-maintained neurons
with addition of cycloheximide and examined the levels of
XIAP, cIAP-1, and cIAP-2 after 24 h of protein synthesis in-
hibition. Cycloheximide addition alone to NGF-maintained
Figure 2. XIAP protein levels are reduced when sympathetic neurons 
develop competence. (a) Protein levels of XIAP, cIAP-1, and cIAP-2 
were examined in NGF-maintained neurons ( NGF) and in competent 
neurons that were deprived of NGF in the presence of cycloheximide 
for 24 h ( NGF CHX). Levels of  -tubulin were also examined as 
a loading control. Quantitation of this data ( SEM) from two repre-
sentative experiments is shown in b. (c) Protein levels of XIAP and 
Apaf-1 were examined in NGF-maintained ( NGF) and NGF-
deprived (24 h;  NGF) Bax-deficient neurons. (d) Proteins levels 
of XIAP and Apaf-1 were examined in NGF-maintained ( NGF) 
and NGF-deprived, zVAD-FMK (50 uM)-treated ( NGF zVAD) 
sympathetic neurons. (e) Protein levels of XIAP, cIAP-1, c-IAP-2, 
and Apaf-1 were examined in NGF-maintained neurons ( NGF), 
in NGF-maintained neurons treated with cycloheximide for 24 h 
( NGF CHX), and in NGF-deprived neurons treated with cyclo-
heximide for 24 h ( NGF CHX). Quantitation of this data ( SEM) 
from two representative experiments is shown in f. 
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neurons reduced XIAP levels to 
 
 
 
55% of the untreated,
NGF-maintained control neurons (Fig. 2, e and f). Levels of
cIAP-1 and cIAP-2 were reduced to 
 
 
 
65% of control neu-
rons, indicating that differences in the half-lives of these
IAPs alone cannot account for the selective decrease in XIAP
levels seen in the NGF-deprived competent conditions.
Thus, although the marked reduction in XIAP levels after
NGF deprivation could be partially accounted for by the
global inhibition of protein synthesis seen after NGF with-
drawal, NGF deprivation must also activate other mecha-
nisms that cause the selective decrease in XIAP levels seen in
competent neurons.
If the down-regulation of XIAP protein is important for
the neuronal development of competence, then reduction in
XIAP levels should always correlate with competent neu-
rons. Conversely, XIAP levels should always be maintained
in neurons that are not competent. First, we examined
whether the time course of the reduction in XIAP protein
levels after NGF deprivation correlated with the time course
of development of competence. Sympathetic neurons de-
velop competence and become permissible for cytochrome
 
c
 
–mediated caspase activation only after 
 
 
 
24 h of NGF
deprivation (Deshmukh and Johnson, 1998). Consistent
with the time course of development of competence, signifi-
cant reduction in XIAP protein levels were detected only af-
ter 20–30 h of NGF deprivation (Fig. 3 a). Second, depo-
larizing concentrations of potassium (with 35 mM KCl)
or elevation of intracellular cyclic AMP levels (with 400
 
 
 
M 8-(4-chlorophenylthio)adenosine-3
 
 
 
-5
 
 
 
-cyclic monophos-
phate; CPTcAMP) blocks the development of the compe-
tence pathway in NGF-deprived neurons (Deshmukh et al.,
2002). Consistent with the ability of KCl and CPTcAMP to
inhibit the development of competence, XIAP levels were
maintained in both KCl- and CPTcAMP-treated neurons,
despite 24 h of NGF deprivation (Fig. 3 b).
The observed changes in XIAP protein levels in com-
petent neurons raised the possibility that perhaps XIAP
mRNA levels were also regulated with the development of
competence in sympathetic neurons. Steady-state levels of
mRNAs were examined by a fluorescence-based, quantita-
tive RT-PCR method in these neurons. In the competent,
NGF-deprived, cycloheximide-treated neurons, the levels of
XIAP mRNA were substantially reduced to 
 
 
 
20% of NGF-
maintained neurons (Fig. 4 a). Levels of the control glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) mRNA in
competent neurons were 75% of the NGF-maintained lev-
els. The time course of the fall in XIAP levels indicate that
the significant reduction in XIAP mRNA occurs only after
12 h of NGF deprivation (Fig. S2, available at http://
www.jcb.org/cgi/content/full/jcb.200307130/DC1). We
also examined whether levels of cIAP-1 and cIAP-2 were al-
tered in competent neurons. In contrast to the marked re-
duction in XIAP mRNA levels in competent neurons, the
levels of cIAP-1 mRNA were slightly increased to 110%,
whereas those of cIAP-2 mRNA were slightly decreased to
Figure 3. Reduction in XIAP protein levels correlates with neuronal 
development of competence in multiple conditions. (a) Examination 
of the time course of reduction in XIAP levels during development 
of competence. Levels of XIAP or Apaf-1 (control) protein were 
examined in NGF-maintained neurons ( NGF) and in parallel cultures 
of neurons that were deprived of NGF in the presence of cyclo-
heximide for the indicated times after NGF deprivation ( NGF CHX). 
Arrow points to the band corresponding to XIAP. (b) Levels of XIAP 
or tubulin (control) protein were examined in NGF-maintained neurons 
( NGF) and in NGF-deprived neurons (24 h) in which the com-
petence pathway was blocked with the addition of 35 mM KCl 
( NGF KCl) or 400  M CPTcAMP ( NGF cAMP). For comparison, 
XIAP levels were also examined in the competent, NGF-deprived, 
cycloheximide-treated ( NGF CHX; 24 h) neurons. These data are 
representative of multiple experiments.
Figure 4. XIAP mRNA levels are significantly reduced in neurons 
that develop competence. (a) Levels of XIAP and GAPDH (control) 
mRNAs were examined with quantitative RT-PCR analysis in sym-
pathetic neurons that were either maintained in NGF ( NGF) or 
deprived of NGF in the presence of cycloheximide for 36 h to de-
velop competence ( NGF CHX). Levels of these mRNAs were also 
examined in competent neurons that were treated with NGF readdition 
for 24 h to reverse the competence state ( NGF CHX →  NGF). 
(b) Levels of mRNAs of cIAP-1 and cIAP-2 along with those of XIAP 
and GAPDH were determined in the competent NGF-deprived, 
cycloheximide-treated neurons ( NGF CHX; 36 h) and expressed 
as a percentage of the mRNA levels in NGF-maintained neurons. 
Data are mean   SEM of two to three experiments.Neuronal apoptosis requires the removal of XIAP | Potts et al. 793
70% in competent neurons as compared with the NGF-
maintained neurons (Fig. 4 b). Finally, we examined whether
XIAP mRNA levels were restored in conditions where com-
petence is reversed with NGF readdition. Consistent with
the observation that readdition of NGF for 24 h reverses
competence (Deshmukh et al., 2002), we found XIAP
mRNA levels to be restored to 85% of the NGF-maintained
levels by 24 h after NGF readdition (Fig. 4 a).
Thus, changes in XIAP levels, both mRNA and protein,
correlated with the competence status of sympathetic neu-
rons under all conditions that we examined. Among the
IAPs that we examined, XIAP mRNA and protein levels
were selectively reduced when neurons developed compe-
tence and became susceptible to cytochrome c–mediated
apoptosis. In contrast, XIAP levels were maintained or re-
stored under conditions when neurons were not competent
and exhibit resistance to cytosolic cytochrome c.
XIAP is required for regulating caspase activation 
during sympathetic neuronal apoptosis
If the reduction in XIAP levels were sufficient to permit cy-
tochrome  c to induce apoptosis in sympathetic neurons,
then one prediction of this model is that although cytosolic
cytochrome c alone is not sufficient to induce apoptosis in
wild-type neurons, it should be able to promote caspase acti-
vation and apoptosis in XIAP-deficient sympathetic neu-
rons. To test this hypothesis, we isolated sympathetic neu-
rons from XIAP-deficient mice (Harlin et al., 2001) and
examined whether cytosolic microinjection of cytochrome c
was sufficient to induce death in these neurons. In contrast
to NGF-maintained wild-type neurons that are resistant to
cytochrome c, the XIAP-deficient neurons were susceptible
and died rapidly with cytosolic microinjection of cyto-
chrome c (Fig. 5, a and b). Less than 10% of the XIAP-defi-
cient neurons were alive within 4 h after cytochrome c mi-
croinjections, and only 1% remained alive by 24 h after the
injections. In contrast,  80% of the wild-type neurons re-
mained viable even 24 h after cytochrome c injections (Fig.
5 a). Injection of yeast cytochrome c, which does not pro-
mote caspase activation in mammalian cells (Ellerby et al.,
1997), did not induce cell death in either the wild-type or
XIAP-deficient neurons (Fig. 5 a).
We examined whether reintroduction of XIAP into the
XIAP-deficient neurons was sufficient to restore resistance to
cytosolic cytochrome c. Microinjection of XIAP into the
XIAP-deficient neurons was sufficient to promote resistance
to cytosolic cytochrome c as  90% of these cells were viable
even 12 h after cytochrome c injections. In contrast, only
11% of the vector alone–injected XIAP-deficient neurons
remained viable 12 h after cytochrome c injections (Fig. 5 c).
We also examined whether XIAP deficiency affected the
overall time course of neuronal death after NGF depriva-
Figure 5. XIAP is necessary for the postcytochrome c regulation 
of caspase activation in sympathetic neurons. (a) NGF-maintained 
sympathetic neurons from XIAP-deficient ( / ) or wild-type ( / ) 
littermate mice were microinjected with either bovine or yeast 
cytochrome c. Survival of the injected neurons was assessed at the 
indicated times. Data shown are mean   SEM of three independent 
experiments. (b) Phase contrast micrographs of wild-type (XIAP / ) 
and XIAP-deficient (XIAP / ) neurons are shown. Neurons that 
were injected with bovine cytochrome c (and rhodamine dextran) 
were identified by fluorescence micrographs for the same field and 
are marked with arrowheads. Bar, 10  m. (c) Reintroduction of XIAP 
into XIAP-deficient neurons restores resistance to cytosolic micro-
injection of cytochrome c. NGF-maintained, XIAP-deficient sympa-
thetic neurons were coinjected with plasmids expressing either XIAP 
or vector alone and EGFP. After 24 h to allow for expression, the 
injected neurons were reinjected with cytochrome c and survival of 
the cytochrome c–injected cells was determined 12 h after the in-
jections. Data are mean   SEM of three independent experiments.
Figure 6. Wild-type and XIAP-deficient sympathetic neurons show 
no differences in the time course of death after NGF withdrawal. 
Equal numbers of wild-type and XIAP-deficient sympathetic neurons 
were either maintained in NGF or deprived of NGF for 12, 24, and 
48 h. The number of neurons that became committed to die at those 
times was determined by replacing the media with NGF-containing 
media and counting the number of neurons that could be rescued 
after 7 d of NGF readdition. Rescued neurons show healthy, phase 
bright cell bodies. Data shown are mean   SD of three experiments.794 The Journal of Cell Biology | Volume 163, Number 4, 2003
Figure 7. Release of endogenous cytochrome c and Smac are not sufficient to overcome the XIAP-mediated postcytochrome c inhibition 
in NGF-maintained sympathetic neurons. (a) NGF-maintained neurons were either left untreated or treated with 3 mM H2O2 for 1 h. The status 
of cytochrome c and Smac in these neurons was examined 3 h after the H2O2 exposure by immunohistochemical techniques. Micrographs 
show that whereas untreated, NGF-maintained neurons show a punctate, mitochondrial pattern of staining for both cytochrome c (red) and 
Smac (green), H2O2 exposure induces the loss of both cytochrome c and Smac staining from the mitochondria in these neurons. Bizbenzimide 
staining shows the nuclei (blue). (b) Quantitation of the loss of mitochondrial cytochrome c and Smac from these neurons in response to the 
transient H2O2 treatment. Approximately 100 neurons were counted to determine the status of cytochrome c and Smac in untreated or H2O2-
treated neurons. (c) Wild-type (XIAP / ) or XIAP-deficient (XIAP / ) sympathetic neurons were maintained in NGF and either left untreated 
or transiently exposed to H2O2 as described in panel a. The status of cytochrome c (red) and activated caspase-3 (green) in these neurons was 
examined by immunohistochemical techniques. Bizbenzimide staining shows the nuclei (blue). For untreated neurons, the staining patterns 
for both XIAP /  and XIAP /  conditions are identical but only the image for XIAP /  is shown. The percentage of neurons showing 
activated caspase-3 immunostaining after transient H2O2 exposure in the wild-type (XIAP / ) or XIAP-deficient (XIAP / ) is quantitated in 
panel d. (e) Sympathetic neurons were either maintained in NGF ( NGF) or made competent by depriving them of NGF in the presence of 
cycloheximide for 24 h ( NGF CHX). These neurons were either left untreated or treated with H2O2, and the status of cytochrome c (red) 
and activated caspase-3 (green) in these neurons was examined. For untreated neurons, the staining patterns for both  NGF and –NGF CHX 
conditions are identical but only the image for  NGF CHX is shown. The percentage of neurons showing activated caspase-3 immunostaining 
after transient H2O2 exposure in the NGF-maintained ( NGF) or competent, ( NGF CHX) conditions is quantitated in panel f. Data shown 
in b, d, and f are mean   SD of three experiments. Bars: (a, c, and e) 10  m.Neuronal apoptosis requires the removal of XIAP | Potts et al. 795
tion. Cultures of sympathetic neurons from XIAP-deficient
mice and their wild-type littermates were deprived of NGF,
and their survival was assessed at 12, 24, and 48 h after NGF
deprivation. No differences were observed in the time
courses of death after NGF deprivation between the wild-
type and XIAP-deficient neurons (Fig. 6). Thus, although
removal of XIAP made neurons vulnerable to cytosolic cyto-
chrome c, XIAP deficiency alone did not change the overall
kinetics of apoptosis after NGF withdrawal. These results
are consistent with the idea that XIAP functions as a critical
safety brake to protect against aberrant caspase activation if
cytochrome  c is accidentally released from mitochondria.
Whereas removal of XIAP was necessary for activating cas-
pases in these neurons, the deletion of this safety mechanism
by itself did not alter the kinetics of apoptosis after NGF
deprivation.
Hydrogen peroxide (H2O2)–induced release of 
endogenous cytochrome c and Smac are not 
sufficient to overcome XIAP in neurons
The results thus far indicate that removal of XIAP is both
necessary and sufficient to allow cytochrome c to activate cas-
pases and apoptosis in sympathetic neurons. Although our
data show that the NGF deprivation–induced competence
pathway promoted a marked reduction in XIAP levels, an-
other potential mechanism by which XIAP function could be
inhibited in these neurons is by the mitochondrial release of
endogenous Smac. To examine whether endogenous Smac
and cytochrome c are sufficient to overcome the XIAP inhibi-
tion and permit caspase activation in these neurons, we in-
duced the release of these mitochondrial proteins by treating
neurons with H2O2. H2O2 induces the release of mitochon-
drial cytochrome c in sympathetic neurons (Kirkland et al.,
2002). First, we optimized conditions and found that an ex-
posure of 3 mM H2O2 for 1 h induced the release of mito-
chondrial cytochrome c in  90% of the neurons by 3 h after
the treatment (Fig. 7, a and b). Released cytochrome c is not
detected in the cytosol because once translocated from the
mitochondria, cytochrome c presumably gets degraded in
these neurons (Deshmukh and Johnson, 1998; Neame et al.,
1998). Second, we examined whether endogenous Smac was
also released along with cytochrome c under these conditions.
All detectable Smac was also released from the mitochondria
in  90% of neurons with H2O2 treatment (Fig. 7, a and b).
Like cytochrome c, the released Smac is also presumably de-
graded in the cytosol of these neurons. Thus, transient H2O2
treatment induced the loss of both cytochrome c and Smac
from the mitochondria in sympathetic neurons.
Next, we examined whether the H2O2-induced release of
cytochrome c and Smac was sufficient to activate caspases in
these neurons. Untreated neurons showed the expected
punctate, mitochondrial distribution of cytochrome c and
no staining for activated caspase-3. Surprisingly, even with
H2O2 treatment, despite the release of all detectable endoge-
nous cytochrome c and Smac, virtually none of the neurons
( 2%) exhibited any caspase-3 activation in wild-type neu-
rons (Fig. 7, c and d).
The inability of endogenous cytochrome c and Smac,
which were released from mitochondria by H2O2 treatment,
to activate caspases could be because of their inability to
overcome XIAP inhibition in these neurons. To test this hy-
pothesis, we examined whether the H2O2-induced release of
endogenous cytochrome c and Smac were sufficient to acti-
vate caspases in XIAP-deficient neurons. In contrast to the
results in wild-type neurons, H2O2 treatment induced a ro-
bust activation of caspase-3 in XIAP-deficient neurons in
 25% of the cells (Fig. 7, c and d). The number of cells that
show caspase activation at any given time is not expected to
be very high because cells in which caspases become acti-
vated undergo rapid apoptosis and die. Thus, H2O2-induced
release of endogenous cytochrome c and Smac, although not
sufficient to overcome XIAP inhibition and permit caspase
activation in wild-type sympathetic neurons, induced rapid
caspase activation in XIAP-deficient neurons.
To determine whether the down-regulation of XIAP in-
duced by the competence pathway was sufficient to permit
caspase activation by endogenous cytochrome c and Smac, we
examined whether H2O2 exposure induced caspase activation
in competent, NGF-deprived cycloheximide-treated neurons.
Like in the XIAP-deficient neurons, H2O2 treatment induced
robust caspase activation in competent sympathetic neurons
(Fig. 7, e and f). The inability of endogenous Smac release
alone to overcome XIAP inhibition in NGF-maintained neu-
rons underscores the importance of the competence pathway
in removing XIAP and permitting endogenous cytochrome c
to activate caspases in sympathetic neurons.
Discussion
Primary sympathetic neurons, unlike most mitotic cells, are
remarkably resistant to cytosolic microinjection of cyto-
chrome c. In this paper, we investigated the mechanism be-
hind the stringent postcytochrome c regulation of caspase
activation in sympathetic neurons. We report that the in-
ability of cytochrome c to induce apoptosis in these neurons
is because of an essential function of endogenous XIAP in
regulating caspase activation postcytochrome c. Our results
are consistent with the model in which removal of XIAP is
both necessary and sufficient to allow cytochrome c–medi-
ated caspase activation during sympathetic neuronal apopto-
sis. These results are the first to identify a mammalian cell
type in which apoptosis is regulated postcytochrome c by en-
dogenous XIAP.
Down-regulation of XIAP during sympathetic 
neuronal apoptosis
NGF deprivation–induced sympathetic neuronal apoptosis
requires activation of both the cytochrome c release and the
development of competence pathways. We found that upon
NGF deprivation, the competence pathway induced a dra-
matic reduction in the levels of XIAP mRNA and protein in
sympathetic neurons (Figs. 2 and 3). These data provide in-
sight into how the competence pathway is able to overcome
the neuronal resistance to cytosolic cytochrome c and permit
caspase activation and apoptosis in these neurons. Other sit-
uations in which sympathetic neurons become competent
and die with cytochrome c, such as after axotomy (Fletcher
et al., 2000), may also induce similar mechanisms that re-
move XIAP. Decreases in XIAP levels have also been ob-
served in other neurons undergoing cell death in vivo (Gue-796 The Journal of Cell Biology | Volume 163, Number 4, 2003
gan et al., 2001; Korhonen et al., 2001; Ishigaki et al., 2002;
Perrelet et al., 2002).
We found no evidence of XIAP cleavage during the devel-
opment of competence as no XIAP cleavage product was
found to accumulate in NGF-deprived, competent neurons
(Fig. S3 a, available at http://www.jcb.org/cgi/content/full/
jcb.200307130/DC1). Also, in contrast to the caspase-medi-
ated cleavage of DIAP1 seen in Drosophila (Ditzel et al.,
2003), the loss of XIAP could not be blocked with caspase
inhibition in sympathetic neurons (Fig. 2 d). We also exam-
ined the possibility that XIAP might be targeted for protea-
some-mediated degradation in these neurons, as is seen dur-
ing thymocyte apoptosis (Yang et al., 2000). However, no
ubiquitination of endogenous XIAP was detected in primary
sympathetic neurons after NGF withdrawal (not depicted),
and addition of the proteasome inhibitor lactacystin did not
block the reduction in XIAP levels seen in NGF-deprived
neurons (Fig. S3 b). A recent paper has identified the sites on
XIAP that can be ubiquitinated in cells (Shin et al., 2003).
The specific importance of the ubiquitin pathway in degrad-
ing XIAP in neurons may require examining whether mu-
tant XIAP that cannot be ubiquitinated are also targeted for
removal in NGF-deprived, competent sympathetic neurons.
Because NGF deprivation induces an overall reduction
in neuronal metabolism (Deckwerth and Johnson, 1993),
some decrease in the steady-state levels of all proteins is ex-
pected in NGF-deprived sympathetic neurons. However, al-
though levels of cIAP-1, cIAP-2, and Apaf-1 protein were
reduced (by 20–35%) after NGF deprivation, these de-
creases were small compared with the  70% decrease in
XIAP levels observed under these conditions (Fig. 2). Im-
portantly, total inhibition of protein synthesis with cyclo-
heximide addition alone in NGF-maintained neurons in-
duced a 45% reduction in XIAP levels (Fig. 2). Therefore,
the turnover of XIAP protein after the fall in protein synthe-
sis after NGF deprivation (Deckwerth and Johnson, 1993)
could be one factor that contributes to the marked reduction
in XIAP levels in NGF-deprived competent neurons. How-
ever, cycloheximide addition alone to NGF-maintained
neurons is not sufficient to induce competence (Deshmukh
and Johnson, 1998). The additional decrease in XIAP levels
(25% above those seen with total inhibition of protein syn-
thesis) that is seen in the NGF-deprived conditions, and is
presumably important for the development of competence,
could be mediated by other posttranslational mechanisms
induced under the NGF deprivation conditions.
Essential function of endogenous XIAP in regulating 
caspase activation in sympathetic neurons
Our data show that whereas wild-type sympathetic neurons
are remarkably resistant to cytosolic cytochrome c, the
XIAP-deficient neurons exhibited no resistance and died
rapidly with cytosolic cytochrome c (Figs. 5 and 7). Further-
more, restoring XIAP expression in the XIAP knockout neu-
rons restored the resistance to cytosolic cytochrome c in
these neurons (Fig. 5 c). These results identify XIAP as an
essential postcytochrome c regulator of caspase activation in
sympathetic neurons.
Although XIAP deficiency made sympathetic neurons vul-
nerable to cytosolic cytochrome c, it did not change the over-
all time course of apoptosis after NGF withdrawal (Fig. 6).
Antisense-mediated depletion of XIAP also does not change
the time course of sympathetic neuronal death after NGF
deprivation (Troy et al., 2001). We have previously shown
that the time courses of cytochrome c release and develop-
ment of competence (removal of XIAP) after NGF depriva-
tion are very similar, with 50% of neurons having released
cytochrome c and developed competence by 18–20 h after
NGF withdrawal (Deshmukh and Johnson, 1998). Thus, by
the time the neuron reaches the point of cytochrome c re-
lease, it also removes XIAP, thereby permitting caspase acti-
vation and apoptosis to occur in these neurons. Apoptosis in
XIAP-deficient neurons, although no longer needing the
competence pathway to remove XIAP, is still dependent on
the release of cytochrome c and therefore occurs with a time
course that is indistinguishable from wild-type neurons.
Removal of XIAP during sympathetic neuronal 
apoptosis: Relative importance of the competence 
pathway versus mitochondrial release of Smac
We found that H2O2-induced mitochondrial release of
endogenous Smac and cytochrome c was not sufficient to
overcome XIAP inhibition and activate caspases in NGF-
maintained sympathetic neurons (Fig. 7). Thus, although
exogenously microinjected, excess Smac is capable of remov-
ing XIAP inhibition in these neurons (Fig. 1; Deshmukh et
al., 2002), levels of endogenous Smac may simply be insuffi-
cient to overcome XIAP in these cells. However, in compe-
tent neurons, which have markedly decreased XIAP levels,
and in XIAP-deficient neurons, the H2O2-induced release of
endogenous cytochrome c and Smac induced robust caspase
activation (Fig. 7). Consistent with this observation, recent
data show that NGF-deprived Bax  /  competent neurons
are more susceptible to H2O2 exposure than NGF-main-
tained sympathetic neurons (Kirkland et al., 2002). These
results suggest that the competence pathway, and not the re-
lease of endogenous mitochondrial Smac, is likely to be the
predominant mechanism that removes XIAP and permits
caspase activation in sympathetic neurons.
This critical function of XIAP in sympathetic neurons is
presumably to be a “safety brake” that protects against any
accidental caspase activation if cytochrome c is unexpectedly
released into the cytosol of these neurons. Arguably, for such
a safety mechanism to be effective, XIAP must also with-
stand any inhibition from other proteins that may be re-
leased along with cytochrome c, such as Smac, in such acci-
dental situations. Such a safety brake would be particularly
important in postmitotic cells such as sympathetic neurons
that are not replaceable and need to last for the lifetime of
the organism. Similar postcytochrome c protection from
apoptosis is also seen in Xenopus eggs, presumably because
ensuring the survival of gametes is advantageous to the or-
ganism (Tashker et al., 2002). In neurons, physiologically
appropriate apoptotic stimuli such as NGF deprivation
would activate not only the cytochrome c release pathway,
but also the competence pathway to ensure the removal of
the XIAP brake and permit caspase activation.
The regulation of apoptosis in mammalian sympathetic
neurons is conceptually similar to the “gas and brake” model
in Drosophila, where apoptosis requires both the removal ofNeuronal apoptosis requires the removal of XIAP | Potts et al. 797
IAPs and activation of caspases (Rodriguez et al., 2002).
However, in Drosophila, activation of caspases appears to be
constitutive, as removal of DIAP1 alone results in increased
apoptosis and lethality (Wang et al., 1999). In contrast, in
mammalian sympathetic neurons, caspase activation is de-
pendent on both the removal of endogenous XIAP (the
brake) and the initiation of the cytochrome c release path-
way (the gas). These results are consistent with the observa-
tion that XIAP deficiency alone does not cause increased
apoptosis in mammalian cells under normal physiological
conditions (Harlin et al., 2001). However, the XIAP-defi-
cient neurons, like neuronal apoptosis inhibitory protein-
deficient neurons (Holcik et al., 2000), may be predicted to
be more vulnerable if exposed to toxic stimuli that cause mi-
tochondrial damage and cytochrome c release because they
lack the postcytochrome c safety brake.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich or Fisher Scientific, un-
less otherwise stated. Collagenase and trypsin were purchased from Wor-
thington Biochemical Corporation and cycloheximide was purchased from
Tocris Cookson. The pan-caspase inhibitor zVAD-FMK was purchased
from Enzyme Systems Products.
Sympathetic neuronal cultures
Sympathetic neurons were dissected from superior cervical ganglia of post-
natal day zero to one mice (P0–P1) and maintained in culture as described
previously (Deshmukh et al., 2002). Cells were plated on collagen-coated
dishes at a density of 30,000 cells per well for protein lysates, or 2,500
cells per 35-mm dish for microinjection, survival counts, or immunofluo-
rescence experiments. Sympathetic neurons were grown for 4–5 d in the
NGF-containing media before treating them with experimental conditions.
For NGF deprivation, cultures were rinsed twice with medium lacking
NGF followed by addition of goat anti-NGF neutralizing antibody to this
media. Other conditions required the addition of 1  g/ml cycloheximide,
400  M CPTcAMP, or 35 mM KCl to anti-NGF–containing media. Sympa-
thetic neurons from Bax-deficient mice were isolated as described previ-
ously (Deckwerth et al., 1996).
Bacterial expression of recombinant proteins
A COOH-terminal His-tagged bacterial expression plasmid (pET15b) con-
taining mature Smac cDNA (AVPI-Smac; corresponding to amino acids
56–236 of the full-length Smac protein) was provided by C. Du (Stowers
Institute, Kansas City, MO). The initiating Met in the “AVPI-Smac” protein
is removed during bacterial expression by the aminopeptidase activity be-
cause of the presence of Ala as the second residue (Chai et al., 2000). To
generate the “MVPI-Smac” protein, the first Ala residue was simply de-
leted by site directed mutagenesis. Because the second residue now is Val
instead of Ala, the initiating Met remains intact, thus generating the MVPI-
Smac protein. Primer sequences used for this site directed mutagene-
sis were: forward 5 -AGAAGGAGATATACCATGGTTCCTATTGCAGAG-
3  and reverse 5 -CTGTGCAATAGGAACCATGGTATATCTCCTTCT-3 .
Escherichia coli BL21-(DE3) bacteria strain (Stratagene) were transformed
with either the AVPI-Smac– or MVPI-Smac–containing plasmids. Bacte-
rial cultures were grown in Luria Bertani media until reaching a density of
OD600   0.6. Expression of protein was induced with 1 mM IPTG for 3 h
at 37 C and cells were harvested by centrifugation. The bacterial pellet
was lysed by sonication and Ni-NTA agarose beads (QIAGEN) were used
to purify the His-tagged protein according to the manufacturer’s instruc-
tions. The eluted fractions were analyzed by SDS-PAGE and fractions
containing the desired protein were pooled and dialyzed overnight at 4 C
into dialysis buffer (20 mM Hepes, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM
EDTA, 0.5 mM EGTA, and 1 mM DTT, pH 7.4) and stored in aliquots at
 80 C until needed.
Microinjection and quantitation of cell survival
Our method for microinjecting sympathetic neurons with cytochrome c
has been described previously (Deshmukh and Johnson, 1998). In brief,
sympathetic neurons were microinjected using Femtotip II needles (Eppen-
dorf Inc.) and a Narashigi micromanipulator mounted on an inverted fluo-
rescence microscope (Leica). The microinjection solution (100 mM KCl
and 10 mM KPi, pH 7.4) contained 4 mg/ml of rhodamine dextran dye to
mark the injected cells. The concentration of bovine cytochrome c in-
jected was 10–15 mg/ml, and that of mature Smac was 1 mg/ml. Immedi-
ately after the injections, the number of viable cells injected was deter-
mined by counting the number of rhodamine-positive cells that had intact,
phase-bright cell bodies. This method of assessing neuronal survival corre-
lates well with other cell survival assays such as trypan blue exclusion and
staining with calcien AM (Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200307130/DC1). At various times after injections, the
number of viable, injected neurons remaining was determined by using
the same counting criteria and expressed as a percentage of the original
number of microinjected cells.
In experiments involving microinjection of the XIAP-expressing plasmid
(pEBB-XIAP; a gift provided by C. Duckett, University of Michigan, Ann Ar-
bor, MI), neurons were injected in the nucleus with 200 ng/ l of the plas-
mid DNA along with 50 ng/ l EGFP-expressing DNA (CLONTECH Labora-
tories, Inc.) in microinjection buffer. After 24 h to allow for expression,
GFP-expressing cells were identified by fluorescence microscopy and rein-
jected with cytochrome c (as described in the previous paragraph). The sur-
vival of these double injected cells was assessed 12 h after cytochrome c
injections.
Western blot analysis
Sympathetic neuronal cultures were washed in PBS and harvested in RIPA
buffer (150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
50 mM Tris-HCl, pH 8.0, and protease inhibitor cocktail), and subjected to
SDS-PAGE analysis as described previously (Deshmukh et al., 2002). For
quantitation, the Western blots were developed with ECL-plus reagents
(Amersham Biosciences) and analyzed on a Typhoon fluorescent imager
(Amersham Biosciences) using the ImageQuant software (Amersham Bio-
sciences). The specific antibodies used in experiments are listed in the On-
line supplemental materials and methods section, available at http://
www.jcb.org/cgi/content/full/jcb.200307130/DC1.
Quantitation of mRNA expression
Our method of quantitative RT-PCR analysis is a modification of a previ-
ously published protocol (Estus et al., 1994), where we substituted the ra-
dioactivity-based detection method with a fluorescence-based detection
technique. In brief, parallel cultures of sympathetic neurons with equal
cell numbers plated were grown under the appropriate conditions and
total RNA was harvested using QIAGEN RNAeasy kit. RNA was con-
verted to cDNA by Superscript II reverse transcriptase (Invitrogen) using
random hexamers (Invitrogen) as primer templates. Primer sets for
GAPDH, XIAP, cIAP-1, and cIAP-2 (see Online supplemental material)
were first analyzed for their linear range of amplification by varying the
number of cycles and amount of input cDNA. The optimal cycle num-
ber that yielded a detectable, linearly amplified product was found to be
18 cycles for GAPDH and 22 cycles for XIAP, cIAP-1, and cIAP-2. PCR
was performed for the indicated number of cycles for each primer pair
and the PCR products were separated on an 8% polyacrylamide nonde-
naturing gel. The gel was stained with Sybr Green I (Molecular Probes)
for 45 min on a rocker and the stained PCR products were visualized on
a Typhoon fluorescence imager and quantitated using ImageQuant soft-
ware.
Genotyping of XIAP  /  mice
Genotyping was performed by digesting tail DNA overnight in genotyping
buffer (100 mM Tris-HCl, pH 8.5, 200 mM NaCl, 5 mM EDTA, 0.2% SDS,
10 mg/ml proteinase K) at 55 C. DNA was precipitated by gently adding
three volumes of ice-cold ethanol to the supernatant and spooling at the
interface. The PCR primers used for genotyping are listed in the Online
supplemental materials and methods section.
Quantitation of neuronal survival after NGF deprivation
Sympathetic neuronal survival after 0, 12, 24, and 48 h of NGF depriva-
tion was assessed by determining the percentage of cells that could be res-
cued by adding back NGF to the cultures at those times. Equal numbers of
sympathetic neurons plated in multiple dishes were deprived of NGF for
the indicated times, rinsed three times, and incubated in fresh NGF-con-
taining media. After 7 d of NGF readdition, the rescued neurons were
clearly identifiable with large and phase-bright cell bodies, whereas the
nonrescued neurons atrophied and degenerated. All rescued cells in the
dish were counted and expressed as a percent of the number of cells in
the 0 h, untreated condition.798 The Journal of Cell Biology | Volume 163, Number 4, 2003
Immunofluorescence analysis
Immunofluorescence analysis on sympathetic neuronal cultures was per-
formed essentially as described previously (Deshmukh and Johnson,
1998). The specific antibodies used in experiments are listed in the Online
supplemental materials and methods section.
Transient exposure of sympathetic neurons to H2O2 was done by treat-
ment of neurons with 3 mM H2O2 for 1 h, with a change into fresh H2O2
containing media after 30 min. Cells were washed three times with NGF-
containing (AM50) media and allowed to incubate at 37 C for three addi-
tional hours in AM50 media. Cells were fixed and subjected to immunoflu-
orescence analysis.
Online supplemental material
Fig. S1 shows the assessment of neuronal survival after cytochrome c mi-
croinjections using multiple techniques. Fig. S2 shows the time course of
decrease in XIAP mRNA levels after NGF deprivation. Fig. S3 shows a full-
length Western blot of extracts from NGF-maintained and NGF-deprived,
cycloheximide-treated sympathetic neurons probed for XIAP. This figure
also shows the inability of lactacystin to block the decrease in XIAP levels
in the NGF-deprived, competent neurons. Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200307130/DC1.
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